AMRI has purchased FineKem Laboratories Pvt. Ltd., a manufacturing facility located in Aurangabad, India. This acquisition will add to the company’s ability to make custom pilot scale intermediates in India, which is expected to begin 2Q2008, and also adds another compound, ISMN (Isosorbide Mononitrate), to AMRI’s generics portfolio.     In the next few months, AMRI plans to upgrade the existing facilities to make them compliant with FDA regulations for manufacturing clinical trial materials ...